Remitly has closed a USD12.5 million Series B funding round led by DFJ with participation from DN Capital and existing investors QED Investors and Trilogy Equity Partners.  DFJ partner William Bryant will join Remitly’s board of directors. Remitly will use the new capital to expand its team, scale marketing efforts, and broaden the service to include new countries. While the global economy becomes more integrated through technology, international money transfers remain antiquated. There are more than 200 million people who live abroad and send money home. These customers use remittance services that are often riddled with high and hidden fees,

Trax Technologies has completed its previously disclosed majority investment in Trax, made in partnership with Trax’s current management team, led by Founder and CEO J Scott Nelson.  The terms of the transaction have not been disclosed. “With this transaction complete, we are excited to continue building the Trax platform and services in support of our current and future global customer base,” says Nelson. “This investment will support further development, deployment, and support of existing and new products and services benefiting both buyers and sellers of logistics services.”

Healthcare investment firm Vivo Capital has held the final closing of Vivo Capital Fund VIII at USD750 million, which brings the firm's total funds under management to more than USD1.7 billion. Vivo plans to invest the capital primarily in later development stage pharmaceutical and medical device companies in the US and in revenue stage healthcare companies in greater China. Vivo plans to continue assisting companies in both countries in their efforts to forge cross-border partnerships, enabling companies to acquire new products and expand the market for their existing products. Vivo also intends to continue its successful strategies of building companies

K2 Capital Partners has held the final closing of its debut fund. Investors include leading investment institutions, family offices, and high net worth individuals. K2 Capital Partners is targeting well-established, profitable lower middle market companies with sales between USD10 million and USD40 million operating in growing industries. The firm’s strategy is to focus on smaller businesses which fall below the investment parameters of most investment firms, and offer a successful exit path for business owners. K2 Capital Partners will invest in businesses that can benefit from the firm’s significant capital base, deep industry relationships, and substantial operational resources. It will

Stanhope Capital, the global investment office, is adding significant resources in private equity to address growing client demand for further investments in this area.  Edward Clive, a Senior Director within the firm’s investment research department, has been appointed Head of Private Funds. He previously worked at Lazard and Vantage Group, and has been with Stanhope for five years. In addition, Jerome Sibony has been appointed as Head of Direct Investments.  Sibony, who has over 15 years of experience in direct private equity, joins Stanhope Capital from Neo Investment Partners where he was the Senior Principal on its EUR300 million Small/Mid

ARX Equity Partners, together with experienced healthcare investor Joseph Priel, has completed the 100% buy-out of Slovenian healthcare services provider, Diagnosticni Center Bled doo (DCB). Details of the transaction have not been disclosed.  DCB is the largest private healthcare service provider in Slovenia. The Company provides comprehensive outpatient and inpatient medical services in four locations. DCB performs more than 20,000 specialist examinations each year, primarily in the areas of gastroenterology and urology. ARX acquired DCB in order to utilize its robust existing business as a platform to further consolidate and grow its leading position in the Slovenian diagnostics sector.  Priel